You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
ScanSource raised its FY27 outlook after net sales grew 30% year-over-year, forecasting $3.8 billion to $4 billion in net sales, $175 million to $185 million in adjusted EBITDA, and at least $85 million in free cash flow.
ScanSource reported net sales of 962,294 thousand for the quarter ended September 30, 2026, up 30.1%. Gross profit rose 8.8% to 116,944 thousand, while operating income fell 52.2% to 12,393 thousand.
ScanSource reported first-quarter net sales of $962.3 million, up 30.1%, while GAAP net income fell to $8.7 million. It acquired MicroAge on September 1, 2026 and raised fiscal year 2027 adjusted EBITDA guidance to $175 million to $185 million.
ScanSource reported net sales of $3.23 billion for fiscal year ended June 30, 2026, markets over 65,000 products from approximately 500 suppliers, and serves approximately 25,000 channel sales partners.
ScanSource, Inc.’s 2026 Annual Meeting occurs December 08, 2026 at 9:00 AM EST; voting closes December 07, 2026 11:59 PM ET. Proposals cover director nominees, named executive officer compensation, and ratification of Deloitte & Touche LLP for the fiscal year ending June 30, 2027.
Useful current figures from the complete screener profile.
* Q4 derived as the full year minus Q1 to Q3.
TL;DR. Strong demand drove 30.1% net sales growth, and ScanSource raised FY27 net sales and adjusted EBITDA guidance while adding MicroAge and reaffirming at least $85 million of free cash flow. Profitability weakened on lower-margin large deals, with gross margin down 238 basis points and GAAP net income and adjusted EBITDA declining year-over-year, while Q1 free cash flow was a use of $44.1 million and Brazil net sales declined more than 20% on a constant currency basis.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Illustrative technical + ownership context — a signal mix, not investment advice.
| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $151.55M | FY26 | — |
GAAP → non-GAAP reconciliationGAAP EBITDA (non-GAAP) 133.97M
+1.07M Change in fair value of contingent consideration
+14.06M Share-based compensation
+1.26M Acquisition costs
+119K Cyberattack restoration costs
+1.77M Restructuring costs
+921K Legal settlement
-789K Tax recovery
-838K Insurance recovery, net of payments
= Adjusted EBITDA 151.55M
|
|||
| Adjusted EBITDA margin % non-GAAP | 4.7% | FY26 | — |
| Adjusted EBITDA, TTM (non-GAAP) non-GAAP | $151.55M | TTM Q4 FY2026 | — |
| Adjusted ROIC (non-GAAP) non-GAAP | 14.7% | FY2026 | — |
| Cash conversion cycle | 61 | Q4 FY2026 | — |
| Days sales outstanding in receivables | 73 | Q4 FY2026 | — |
| EBITDA (non-GAAP) non-GAAP | 133.97M | Fiscal year ended June 30, 2026 | — |
| Free cash flow non-GAAP | $113.8M | FY26 | — |
GAAP → non-GAAP reconciliationGAAP GAAP operating cash flow 123.13M
-9.29M Capital expenditures
= Free cash flow 113.85M
|
|||
| Free cash flow (QTR) (Non-GAAP) non-GAAP | -$4.79M | Q4 FY2026 | — |
| Free cash flow (TTM) (Non-GAAP) non-GAAP | $113.84M | TTM Q4 FY2026 | — |
| Inventory turns | 6.6 | Q4 FY2026 | — |
| Invested capital (denominator for Adjusted ROIC) (non-GAAP) non-GAAP | 1.03B | Fiscal year ended June 30, 2026 | — |
| Net debt (non-GAAP) non-GAAP | $13.04M | Q4 FY2026 | — |
| Non-GAAP diluted EPS non-GAAP | $4.24 | Year ended June 30, 2026 filing | — |
| Non-GAAP net income non-GAAP | 91.95M | fiscal year ended June 30, 2026 filing | — |
| Non-GAAP net sales non-GAAP | 3.19B | fiscal year ended June 30, 2026 filing | — |
| Non-GAAP operating income (Consolidated) non-GAAP | 119.7M | fiscal year ended June 30, 2026 filing | — |
| Non-GAAP operating income (Intelisys & Advisory) non-GAAP | 37.17M | fiscal year ended June 30, 2026 filing | — |
GAAP → non-GAAP reconciliationGAAP GAAP operating income 28.58M
+8.75M Amortization of intangible assets
-170K Change in fair value of contingent consideration
= Non-GAAP operating income - Intelisys & Advisory 37.17M
|
|||
| Non-GAAP operating income (Specialty Technology Solutions) non-GAAP | 82.54M | fiscal year ended June 30, 2026 filing | — |
GAAP → non-GAAP reconciliationGAAP GAAP operating income 74.11M
+7.97M Amortization of intangible assets
+1.24M Change in fair value of contingent consideration
-789K Tax recovery, net
= Non-GAAP operating income - Specialty Technology Solutions 82.54M
|
|||
| Non-GAAP pre-tax income non-GAAP | 123.98M | fiscal year ended June 30, 2026 filing | — |
| Non-GAAP SG&A expenses non-GAAP | 311.66M | fiscal year ended June 30, 2026 filing | — |
| Recurring revenue | 161.21M | Fiscal year ended June 30, 2026 | — |
| Recurring revenue gross profit as % of gross profit non-GAAP | 31.5% | Q4 FY2026 Consolidated | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SCSC
this stock
Scansource, Inc.
|
$909.65M | +14.6% | +7.8% | 14.1 | 6.6% |
|
SNX
Td Synnex Corp
|
$18.95B | +58.1% | +17.6% | 14.5 | 2.0% |
|
ARW
Arrow Electronics, Inc.
|
$9.75B | +75.1% | +10.5% | 9.8 | 2.6% |
|
AVT
Avnet Inc
|
$6.91B | +74.6% | +24.5% | 12.6 | 10.8% |
|
NSIT
Insight Enterprises Inc
|
$4.86B | +107.1% | -5.2% | 28.4 | 2.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
ScanSource reported net sales of 962,294 thousand for the quarter ended September 30, 2026, up 30.1%. Gross profit rose 8.8% to 116,944 thousand, while operating income fell 52.2% to 12,393 thousand.
View| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SCSC | +4.6% | -25.4% | -0.4% | -22.5% | +14.6% |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | +2.0% | -24.3% | -0.9% | -22.3% | +4.0% |
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
